Through its program (Takeda for supporting patients), Takeda signed a memorandum of understanding with Hospital 57357, as the first cooperation between the Hospital and the charitable organization. This cooperation is a result of the Company’s trust in the worthiness of the Hospital as a leading model for the delivery of free world class quality services to cancer patients in an equitable manner.
It is noteworthy that Takeda is a biopharmaceutical company that focuses on serving patients according to fine moral values, relying on research and development efforts, pursuing to offer better outcomes to patients across the world. The Company which is concerned with providing life- changing treatments for patients, has a long history in Japan where it started in 1781.
This cooperation is established through Axios, which is an international organization that contributes to supporting health services provision in countries with low and average income, through designing and implementing innovative solutions that would increase the availability of medications, diagnosis and healthcare services for patients in these countries.
The cooperation with 57357 includes offering medications for Hodgkin lymphoma patients and a partial coverage of treatment costs as prescribed by the treating doctor.
The agreement includes cooperation between Axios, Hospital 57357 and Takeda, regarding offering free medications in a timely manner and according to high quality control standards. It also stipulates the monitoring of the medication stock to ensure its availability while preserving the secrecy of all patient’s information.
Our gratitude to Takeda Egypt and Takeda international for the innovative solutions that support patients’ treatment and contribute to removing obstacles that would prevent supplying medications to patients in communities that are unable to afford their cost.